ArticleActa pharmaceutica Sinica. B2019

Upregulation of miR-489-3p and miR-630 inhibits oxaliplatin uptake in renal cell carcinoma by targeting OCT2.

Lu Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.